Oxford vaccine ‘promising’ says BDI scientist
Monash BDI’s Professor Stephen Turner gave a thumbs-up to early data on ChAdOx1, the Oxford University vaccine the Australian Government has signed up to buy if it clears clinical trials, when asked his expert opinion by The Sydney Morning Herald and The Age, WAtoday and stuff. “Of all the data sets I’ve seen, it is one of the most promising,” Professor Turner said. He was commenting in an ‘explainer’ story by the papers detailing how the COVID-19 vaccine works. ChAdOx1 is one of the leaders among more than 165 COVID-19 vaccines under development. Side-effects include fatigue, headaches, muscle aches and fever, but they were mild to moderate, the story said. “It’s a live virus,” Professor Turner said. “There is always a small risk of some sort of reaction against the vaccine. But that’s also a plus. When you feel a bit crappy after getting a vaccine, that’s a sign of the immune system working.”